Hyperlactatemia After Intracranial Tumor Surgery Does Not Affect 6-Month Survival: A Retrospective Case Series

Autor: Peter P de Smalen, Tom J. van Ark, Markus Klimek, Arnaud J P E Vincent, Robert Jan Stolker
Přispěvatelé: Anesthesiology, Neurosurgery
Rok vydání: 2020
Předmět:
Zdroj: Journal of Neurosurgical Anesthesiology, 32(1), 48-56. Lippincott Williams & Wilkins
Journal of Neurosurgical Anesthesiology
ISSN: 0898-4921
DOI: 10.1097/ana.0000000000000594
Popis: Supplemental Digital Content is available in the text.
Background: Patients undergoing neurosurgery frequently exhibit hyperlactatemia. The aim of this study was to identify factors associated with hyperlactatemia and assess how hyperlactatemia impacts survival and hospital length of stay after intracranial tumor surgery. Materials and Methods: This retrospective cohort study included 496 adult patients that underwent surgery between January 1, 2014 and December 31, 2015. We evaluated patient characteristics, surgery characteristics, pH, lactate, and blood glucose from blood samples collected on admission to the high-dependency unit and the morning after surgery, and 6-month outcome data. Results: Hyperlactatemia (>2.0 mmol/L) occurred in >50% of patients, but only 7.7% had acidosis. Postoperative hyperlactatemia was not correlated with 6-month survival (P=0.987), but was correlated with (median [interquartile range]) longer hospital stays (6 [4 to 8.5] d vs. 5 [4 to 8] d; P=0.006), longer surgery duration (4:53 [4:01 to 6:18] h:min vs. 4:28 [3:33 to 5:53] h:min; P=0.001), higher dexamethasone dose (16 [16 to 35] mg vs. 16 [16 to 20] mg; P
Databáze: OpenAIRE